See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Research Area · Vascular Disease

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10462 11(12)-EpETE Exclusive 504435-15-8 ≥98% ✓ 2010-10-28 6.426522176380 11-12-epete 11,12-EEQ; 11,12-Epoxyeicosatetraenoic Acid eicosapentaenoic acids EPAs epoxyeicosatetraenoic EpETE EETeTr cytochromes P450 epoxygenases CYP450 10-[3-2Z,5Z-octadien-1-yl-2-oxiranyl]-5Z,8Z-decadienoic acid 11,12-epoxyeicosatrienoic acid 6.426522176380
519510 11-dehydro Thromboxane B2 EIA Kit - Monoclonal New - 2012-02-08 225.763667638633 11-dehydro-thromboxane-b2-eia-kit-monoclonal 11-dehydro TXB2 ELISA Kit 11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 519501 225.763667638633
13571 13,14-dihydro-15-keto-tetranor Prostaglandin F1α Exclusive 24379-94-0 ≥98% ✓ 2009-11-05 0.989823204420 13-14-dihydro-15-keto-tetranor-prostaglandin-f1 metabolites PGF1α PGF2α tetranors PGFM prostaglandins PGs urinary metabolites prostanoic acids C13 C-13 C14 C-14 C15 C-15 0.989823204420
10004946 14,15-EE-5(Z)-E Exclusive 519038-92-7 ≥98% ✓ 2007-01-15 53.788250460405 14-15-ee-5-z-e 14,15-Epoxyeicosa-5(Z)-enoic Acid 14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE 53.788250460405
10010486 14,15-EE-8(Z)-E Exclusive 519038-93-8 ≥98% ✓ 2008-11-03 14.701847759361 14-15-ee-8-z-e 14,15-Epoxyeicosa-8(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 14.701847759361
10008510 15(R)-Pinane Thromboxane A2 - >98% 2006-06-14 7.662983425415 15-r-pinane-thromboxane-a2 15(R)-PTA2 TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer 7.662983425415
10010635 (±)16-HETE 128914-46-5 ≥98% 2008-06-09 30.316611418048 -16-hete CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension 30.316611418048
10991 16(R)-AFP 07 (free acid) Exclusive 773525-80-2 ≥98% ✓ 2011-08-16 26.645999999999 16-r-afp-07-free-acid prostaglandins I2 PGI2 prostacyclin IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 PGs prostacyclin AFP-07 AFP07 EP prostanoids 26.645999999999
10010638 (±)18-HETE 133268-58-3 ≥97% 2008-06-13 2.947248618784 -18-hete CYP450 eicosanoid metabolism kidney vasodilation CYP2E1 20-HETE 20HETE 18HETE renal hypertension 2.947248618784
10007767 19(R)-HETE 115461-39-7 ≥98% 2008-05-27 9.135911602210 19-r-hete hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE 9.135911602210
10007766 19(S)-HETE Exclusive 115461-40-0 ≥98% ✓ 2010-04-06 39.957384898710 19-s-hete cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction Acids Hydroxyeicosatetraenoic Hydroxyeicosatetraenoic Acids HETE 39.957384898710
13050 1a,1b-dihomo Prostaglandin E1 - >98% 15.396279926335 1a-1b-dihomo-prostaglandin-e1 1a,1b-dihomo PGE1 1a,1b-dihomo-PGE1 prostaglandins 15.396279926335
9000462 2,3-dinor-6-keto Prostaglandin F1α-d9 (sodium salt) - ≥99% deuterated forms (d1-d9) 2010-05-07 20.369447513812 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt 2,3-dinor-6-keto PGF1α-d9 (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated 20.369447513812
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 148.800022099447 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 148.800022099447
15120 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) - ≥95% 15.271049723756 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt 2,3-dinor-6-keto PGF1α (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins 15.271049723756
13120 2,3-dinor Prostaglandin E1 7046-40-4 >98% 28.634060773480 2-3-dinor-prostaglandin-e1 2,3-dinor PGE1 prostaglandins 2,3-dinor-PGE1 erectile dysfunction 28.634060773480
10006330 2,3-dinor Thromboxane B1 - >98% 2005-03-02 69.753749013417 2-3-dinor-thromboxane-b1 2,3-dinor TXB1 metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits 69.753749013417
10467 5,6-DiHETE Exclusive 845673-97-4 ≥97% ✓ 2011-06-13 10.125051302288 5-6-dihete eicosapentaenoic acids EPAs cytochromes P450 P-450 metabolites polyunsaturated fatty metabolites ω-3 omega epoxidation 5(6)-DiHETE DiHETEs epoxide hydrolases CYP450 10.125051302288
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 1.353038674033 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 1.353038674033
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 60.953138121546 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 60.953138121546
515211 6-keto Prostaglandin F1α EIA Kit - 332.470368409385 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 332.470368409385
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 39.352254143646 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 39.352254143646
18112 8,9-EE-14(Z)-E Exclusive - ≥95% ✓ 2009-03-15 13.174889502762 8-9-ee-14-z-e 8,9-Epoxyeicosa-14(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 13.174889502762
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 145.879318600368 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis 145.879318600368
10010569 Acenocoumarol 152-72-7 ≥98% 2008-07-25 1.159602209944 acenocoumarol Sinthrome®; G-23350; Nicoumalone; Acenocoumarin; Sintrom® CYP450 thrombosis vitamin K warfarin bleeding blood coagulation inhibitors inhibits inhibition 1.159602209944
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 189.773494475138 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 189.773494475138
13626 AFP 07 (free acid) Exclusive 788799-13-3 ≥98% ✓ 2011-08-31 13.792541436464 afp-07-free-acid prostaglandins I2 PGI2 PGs prostacyclins IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 AH-23848 prostanoids platelets vasodialation aggregation pulmonary vascular AH23848 AFP07 AFP-07 13.792541436464
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 36.988508287293 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 36.988508287293
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 34.961381215469 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 34.961381215469
13079 ApoAI Blocking Peptide - 2008-09-30 14.779558011050 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots 14.779558011050
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 21.742115232833 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins 21.742115232833
13644 Aspalatone Exclusive 147249-33-0 ≥98% ✓ 2010-02-19 1.521262825572 aspalatone Acetylsalicylic Acid Matol ester antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles 2-(Acetyloxy)benzoic Acid Acid, Acetylsalicylic Acetylsalicylic Acid Aloxiprimum Polopiryna Polopirin Micristin Endosprin Acylpyrin Solupsan Magnecyl Colfarit Acetysal Zorprin Solprin Ecotrin Easprin Dispril Aspirin 1.521262825572
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 64.708784700907 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays 64.708784700907
10493 Atorvastatin 134523-00-5 ≥98% 2010-08-10 7.486740331491 atorvastatin Lipitor®; Cardyl lipitors statins inhibitors inhibits inhibition HMG-CoA HMGCoA HMG CoA reductase mevalonate pathways cholesterol cardiovascular hypercholesterolemia dyslipidemias low density lipoproteins LDLs cytochromes P450 CYP3A4 myocardial infarction strokes low-density 7.486740331491
10011131 BAY-41-8543 Exclusive 256498-66-5 ≥98% ✓ 2009-11-16 19.971519337016 bay-41-8543 soluble guanylate cyclase sGC nitric oxide NO GTP cyclic GMP cGMP agonist stimulator platelet aggregation blood pressure bleeding time thrombosis pulmonary hypertension BAY 41-8543 BAY 41 8543 19.971519337016
10011135 BAY-60-7550 439083-90-6 ≥95% 2009-03-13 55.561077348066 bay-60-7550 inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase 55.561077348066
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 95.979825046041 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 95.979825046041
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 64.277476979742 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 64.277476979742
10010396 CAY10535 Exclusive - >98% ✓ 2008-05-06 198.923480662983 cay10535 TPbeta TPb TP.beta. TPalpha TP.alpha. TPa TXA2 thromboxanes antagonists platelet aggregations U-46619 U46619 198.923480662983
10012447 CG 4305 - ≥95% 2010-05-12 49.515730071033 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 49.515730071033
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 63.879109883364 chemokine-like-receptor-1-polyclonal-antibody GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 63.879109883364
700610 Chloride Colorimetric Assay Kit - 2011-11-18 113.277184530386 chloride-colorimetric-assay-kit chlorides Cl assays kits measures measurements plasma serums urine saliva cells cultures lysates Hg2+ Fe2+ mercury iron mercury-thiocyanate Hg-thiocyanate thiocyanates mercuric mineral humans anions hydration osmotic pressure cation-anion balance vascular intestinal fluids compartments hypochloremia hyperchloremia vomiting renal diseases metabolic acidosis burns dehydration diarrhea congestive heart failure hyperventilation kidneys Lightwood syndromes parathyroid glands pathological ions channels Cystic Fibrosis myotonia congenita Barter's Syndrome 2002 bestrophins proteins hbest1 retinal progressive vision loss vitelliform macular dystrophy Best 113.277184530386
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 48.472629425004 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba U18666A U 18666A U-18666A 48.472629425004
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 48.114404821697 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 48.114404821697
13657 (±)-Clopidogrel (hydrochloride) 90055-48-4 ≥98% 2011-04-11 4.077348066299 -clopidogrel-hydrochloride platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic 4.077348066299
11326 Cyclopiazonic Acid New 18172-33-3 ≥95% 2012-02-23 38.231529337214 cyclopiazonic-acid NSC 117181 inhibitors SERCA calcium Ca2+-ATPase ATPases smooth muscles endothelial cells endothelium cardiovascular vascular biology cardiology mycotoxins Penicillium Aspergillus NSC117181 NSC-117181 38.231529337214
11012 Delphinidin chloride Exclusive New 528-53-0 ≥98% ✓ 2012-03-06 51.662269285860 delphinidin-chloride Ephdine diseases cancers cardiovascular tyrosines kinases vasorelaxation smooth muscles chlorides Cl vasorelaxants inhibitors inhibition inhibits EGFRs epidermal epidermis growth factors receptors HATs histones acetyltransferases anthocyanidins plants pigments anthocyanins blue red colors flowers fruits wines nitric oxides NOs vascular endothelium signaling signalling epithelial estrogens ERa ERalpha ER.alpha. ERα apoptosis cells death autophagy phagocytosis delphinidol 13270-61-6 IdB 1056 IdB-1056 51.662269285860
10012582 Diallyl Disulfide New 2179-57-9 ≥90% 2012-03-12 25.438090853284 diallyl-disulfide Garlicin; DADS; NSC 29228 disulphide dipropenyl H2S hydrogen sulfide cardiovascular diseases neuroscience vascular tone vasorelaxation neuroprotection cardiology hypertension signal transduction NSC29228 NSC-29228 garlic plants allicin 25.438090853284
10010948 DL-Propargyl Glycine (hydrochloride) - ≥98% 2008-08-19 17.522989249343 dl-propargyl-glycine-hydrochloride PAG H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine 17.522989249343
9000295 Eicosapentaenoic Acid methyl ester 2734-47-6 ≥98% 2011-10-07 53.386786372007 eicosapentaenoic-acid-methyl-ester EPA methyl ester vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs 53.386786372007
10010380 ent-8-iso-15(S)-Prostaglandin F2α - ≥98% 2008-04-24 18.670699815837 ent-8-iso-15-s-prostaglandin-f2 ent-8-iso-15-epi-PGF2α; ent-15-epi-F2t-Isoprostane inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane prostaglandins 18.670699815837
11578 Eprosartan (mesylate) New 144143-96-4 ≥98% 2012-05-16 90.719337016575 eprosartan-mesylate SKF 108566J cardiovascular diseases hypertension angiotensin II rennin blood pressure ARB receptors blockers antagonists AT1 mesylate nervous system nerves vessels 90.719337016575
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 5.425531000613 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 5.425531000613
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 12.769097605892 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 12.769097605892
10006407 FTY720 (R)-Phosphate Exclusive 402616-23-3 ≥98% ✓ 2009-05-27 86.029359116022 fty720-r-phosphate FTY720 sphingosines sphingosine-1-phosphates S1P S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 endothelial cells barrier functions immunosuppression FTY-720 FTY 720 86.029359116022
10006408 FTY720 (S)-Phosphate 402616-26-6 ≥98% 2009-05-27 105.514176795580 fty720-s-phosphate (S)-FTY 720P FTY720 sphingosines sphingosine-1-phosphate S1P S1P1 S1P3 S1P4 S1P5 immunosuppression immune modulators Abcc1 Abcb1 transporters cPLA2 cytosolic phospholipase A2 endothelial cells barriers functions FTY720P 105.514176795580
13311 Gö 6983 133053-19-7 ≥98% 2009-10-07 9.212635422620 g-6983 proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 9.212635422620
10136 GPR17 (C-Term) Polyclonal Antibody - 2010-01-19 18.031282995703 gpr17-c-term-polyclonal-antibody G Protein-Coupled Receptor 17 proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes 18.031282995703
13009 GSK264220A 685506-42-7 ≥98% 2009-10-21 5.281325966851 gsk264220a inhibitors endothelial lipases high-density lipoproteins cholesterol HDL-C HDL cardiovascular diseases inhibition inhibited ET 5.281325966851
10851 Guanabenz (hydrochloride) - ≥98% 2011-09-30 0E-12 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0E-12
13345 GYY 4137 Exclusive 106740-09-4 ≥95% ✓ 2009-07-31 73.799575541861 gyy-4137 hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 73.799575541861
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 53.702559852670 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 53.702559852670
700540 Hemoglobin Colorimetric Assay Kit - 2011-05-23 152.475832182319 hemoglobin-colorimetric-assay-kit kits assays measures measurements Hb Hgb globular proteins oxygen O2 lungs tissues cells carbon dioxide CO2 erythrocytes human molecules subunits chains heme groups charged iron Fe Fe2+ tetrapyrrole rings porphyrin covalent bonds monoxide nitric oxides NO hypoxia thiol S-nitrosothiol vasodilatory effects transport hypoxic red blood RBCs vessels sickle-cell anemia thalassemia bone marrow diseases kidney diabetes 152.475832182319
10347 HIF-1α Monoclonal Antibody (Clone H1α67) - 2011-05-09 40.105239410681 hif-1-monoclonal-antibody-clone-h1-67 Hypoxia Inducible Factor-1α WBs western blots IHC immunohistochemistry antibodies HIF-1alpha HIF1a HIF-1a antisera serum cancers H1α67 transcription factors oxidative tumors EPAS-1 EPAS1 EPAS 1 DMOG 2,4-DPD desferrioxamine CoCl2 40.105239410681
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 0E-12 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 0E-12
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 0E-12 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 0E-12
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 0E-12 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 0E-12
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.115469613259 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.115469613259
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 70.191724984653 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 70.191724984653
10011562 L-655,240 103253-15-2 ≥98% 2009-10-15 8.148004143646 l-655-240 platelet aggregation smooth muscle constriction contraction antagonist receptors TXA2 receptor TP thromboxane TPα TPβ TXA2 bronchoconstriction L-655240 L 655240 8.148004143646
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 42.048542987965 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation 42.048542987965
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.875414364640 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 2.875414364640
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 43.918881343360 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 43.918881343360
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 234.812994475138 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 234.812994475138
10010252 Methyl-L-NIO (hydrochloride) 150403-96-6 >98% 2008-02-12 15.730469613259 methyl-l-nio-hydrochloride NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation 15.730469613259
13357 Milrinone 78415-72-2 ≥98% 2011-03-07 310.264618784530 milrinone Primacor®; WIN 47203 inhibitors phosphodiesterases PDE3A PDE3B cAMP vascular diseases cardiovascular effects Sanofi Synthelabo Brand of Milrinone Lactate Sanofi Winthrop Brand of Milrinone Lactate Sanofi Synthelabo Brand of Milrinone Sanofi Brand of Milrinone Lactate Lactate Milrinone Milrinone Lactate Win-47203 Win 47203 Milrinone Corotrope Win47203 Primacor Corotrop inhibits inhibition 310.264618784530
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 63.403342541436 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs 63.403342541436
11214 NKH477 (hydrochloride) New 138605-00-2 ≥95% 2012-02-16 13.389305555556 nkh477-hydrochloride Colforsin Dapropate; Adehl 113462-26-3 adenylate cyclase adenylyl cAMP cyclic AMP vascular diseases cardiovascular cardiac hypotension hypertension analogs cardiac smooth muscles histamines forskolin 11018 HCl hydrochloride NKH-477 NKH 477 13.389305555556
10004971 N,N'-Dicyclohexylurea 2387-23-7 ≥98% 2010-03-17 22.350718232044 n-n-dicyclohexylurea DCU; NSC 17013 hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide Doms-Adrian Brand of Alanine Doms Adrian Brand of Alanine Alanine Doms-Adrian Brand Alanine, L-Isomer Alanine, L Isomer L-Isomer Alanine L-Alanine L Alanine Alanine Abufène 22.350718232044
10010411 NS-304 475086-01-2 ≥98% 2008-04-09 39.075902394106 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.075902394106
10006803 O-1602 317321-41-8 >98% 2005-09-12 11.877928176795 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 11.877928176795
10006804 O-1821 35482-50-9 >97% 2005-09-12 26.649907918968 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 26.649907918968
10004914 O-1918 536697-79-7 >98% 2005-09-09 11.646172059984 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 11.646172059984
11614 Olmesartan Medoxomil New 144689-63-4 ≥98% 2012-05-18 99.077747084100 olmesartan-medoxomil Olmetec; Benicar; CS 866 prodrugs angiotensin II receptors antagonists blood pressure hypertension cardiovascular disease atherosclerosis CS866 CS 866 in vivo RNH-6270 RNH 6270 RNH6270 AT1 AT2 blood pressure cardiovascular parameters CS-866 99.077747084100
13804 OU749 519170-13-9 ≥95% 2010-07-20 1.254530386740 ou749 γ-Glutamyl transferases γ-glutamyl transpeptidases glutathione markers liver dysfunction alcohol abuses biomarkers diabetes cardiovascular diseases cancers acivicin OU-749 OU 749 Mixtures Sulfonamide Sulfonamide Mixtures Sulfonamides 1.254530386740
11345 Paxilline New 57186-25-1 ≥98% 2012-03-01 10.565642497180 paxilline (+)-Paxilline Paxicillin Paxillin inhibitors inhibits inhibitions channels K+ blockers potassium BKCa cells signaling smooth muscle vascular cardiovascular neuronal neuroscience 10.565642497180
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 12.266548802946 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 12.266548802946
11347 Penitrem A New 12627-35-9 ≥98% 2012-03-05 16.753229974160 penitrem-a Tremortin A; NSC 354845 12679-82-2 inhibitors inhibits inhibition channels blockers potassium BKCa cells signaling smooth muscles vascular cardiovascular neuronal neuroscience SLO1 Maxi-K fungal fungus toxins 16.753229974160
10010254 Pentosidine 124505-87-9 ≥98% 2011-02-10 31.147900552486 pentosidine advanced glycation end products AGEs RAGE glycosylation diabetes uremia aging rheumatic arthritis biomarkers 31.147900552486
11006 Piperlongumine 20069-09-4 ≥98% 2011-10-24 57.444354076548 piperlongumine Piplartine 2859-009- 11042-67-4 25343-05-9 Keap1 Nrf2 antioxidants ROS cancers redox platelet aggregation tumorigenesis 57.444354076548
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 14.377154696132 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 14.377154696132
9000336 (R)-(+)-Acenocoumarol 66556-77-2 ≥98% 2009-06-25 1.159602209944 -r-acenocoumarol (R)-(+)-Nicoumalone; (R)-(+)-Acenocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors anticoagulants G-23350 Sintrom Sinthrome coumarins 1.159602209944
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.332392917195 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 256.332392917195
10006415 Ro 48-8071 161582-11-2 ≥98% 2005-06-01 8.098516179952 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 8.098516179952
9000337 (S)-(−)-Acenocoumarol 66556-78-3 ≥98% 2009-06-25 1.159602209944 -s-acenocoumarol (S)-(-)-Nicoumalone; (S)-(-)-Acenocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors inhibition inhibits sintrom sinthrome G-23350 G23350 1.159602209944
89460 Sclerotiorin 549-23-5 ≥98% 2009-03-11 29.300626151013 sclerotiorin Lipoxygenase-1 inhibitor CETP Grb2 Endothelins ETa ETb LO-1 ETs LOs Penicillium soybean inhibits inhibition antagonism antagonists 29.300626151013
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.109856353591 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.109856353591
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% ✓ 2010-01-27 83.825403314916 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 83.825403314916
10007653 (S)-H-1152 (hydrochloride) 451462-58-1 ≥95% 2010-02-25 31.991988950276 -s-h-1152-hydrochloride Rho kinase ROCK cytoskeletal cytoskeleton smooth muscles contractions vasoconstriction neurons neurite inhibitors Y-27632 HA-1077 PKA PKC MLCK H1152 H 1152 inhibition inhibits 451462-58-1 1-(5-Isoquinolinylsulfonyl)-2-Methylpiperazine 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine H-7 H 7 h1152 h-1152 h 1152 31.991988950276
13339 SQ 22,536 New 17318-31-9 ≥95% 2012-05-09 34.665580110497 sq-22-536 NSC 53339 inhibitors inhibits inhibition adenylyl cyclases cAMP platelets iloprost vasorelaxation pulmonary veins vascular smooth muscles prostaglandins PGs PGE PGE1 E1 SQ 22536 SQ22,536 SQ-22,536 34.665580110497
10011348 Taprostene (free acid) Exclusive 108945-35-3 ≥95% ✓ 2009-11-11 43.647412523020 taprostene-free-acid CG 4203; Rheocyclan prostacyclins PGI2 receptors IP IP1 EP4 vascular smooth muscles relaxation analogs potential antagonists tissues preparations CG-4203 CG4203 SE63 SE-63 SE 63 43.647412523020
11615 Telmisartan New 144701-48-4 ≥98% 2012-05-09 89.077747084100 telmisartan Pritor; BIBR 277; Micardis BIBR 277SE BIBR277 BIBR-277 receptors antagonists blood pressure hypertension PPAR PPARγ atherosclerosis cardiovascular disease angiotensin hormones hearts myocardial infarction hypertrophy renal glomerulosclerosis 89.077747084100
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 49.791160220994 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 49.791160220994
10007349 TGX-221 663619-89-4 >98% 2006-02-21 19.982782800379 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis 19.982782800379
10010516 TMP-153 New 128831-46-9 ≥95% 2012-05-08 82.914836446549 tmp-153 Acyl-CoA:cholesterol acyltransferases ACAT cholesterol esterification atherosclerosis inhibitors inhibits inhibition LDL TMP153 TMP-153 cells fatty acids intestinal absorption vascular tissues plasma lipids proteinuria low density lipoprotein high HDL HepG2 L-S180 LS180 L S180 82.914836446549
11120 TPPU Exclusive 1222780-33-7 ≥98% ✓ 2011-10-26 5.145469613259 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 5.145469613259
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 56.391240024554 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 56.391240024554
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 71.116731123388 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 71.116731123388
10010522 U-46619 Glycine methyl ester - >98% 2008-03-24 110.487127071823 u-46619-glycine-methyl-ester TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms 110.487127071823
10010992 W123 Exclusive - ≥98% ✓ 2008-11-14 61.497002762431 w123 FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist 61.497002762431
13531 (−)-Warfarin 5543-57-7 ≥98% 2009-10-01 4.626906077347 -warfarin (S)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants 4.626906077347
13526 (+)-Warfarin 5543-58-8 ≥98% 2009-10-01 2.217856353591 -warfarin (R)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants 2.217856353591
13566 (±)-Warfarin 81-81-2 ≥98% 2009-09-29 1.975116022099 -warfarin Coumadin; Zoocoumarin; Coumafene; Athrombine K; WARF 42 anticoagulants heart attacks strokes clotting blood cardiovascular diseases vitamin K rodenticide anti-coagulants racemic mixture liver accumulation accumulates clots 1.975116022099
10010421 Zaprinast 37762-06-4 ≥98% 2008-09-18 6.124180478821 zaprinast 2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948 sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8 6.124180478821
10010947 β-cyano-L-Alanine 6232-19-5 ≥98% 2008-11-11 9.192958713069 -cyano-l-alanine BCA H2S gasotransmitter inhibitors inhibits inhibition CSE vasodilation inflammation sulfides 9.192958713069
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?